Neuroscience News and Research

RSS

Activation of the prefrontal cortex improves working memory

Psychologists and neurologists invest considerable effort in the study of working memory.

1 Apr 2009

Need for more African American HIV/AIDS researchers

African Americans, who make up 13 percent of the U.S. population, are disproportionately affected by AIDS, accounting for nearly 49 percent of newly diagnosed HIV/AIDS cases nationwide.

1 Apr 2009

Rigorous visual training helps the brain to see again after stroke

By doing a set of vigorous visual exercises on a computer every day for several months, patients who had gone partially blind as a result of suffering a stroke were able to regain some vision, according to scientists who published their results in the April 1 issue of the Journal of Neuroscience.

1 Apr 2009

How microglia diagnose damaged circuits in an in vivo brain

Microglia, immune cells in the brain, is suggested to be involved in the repair of damaged brain, like a medical doctor.

1 Apr 2009

CSHL neuroscientists propose project to comprehensively map mammalian brain circuits

Thirty-seven scientists from Cold Spring Harbor Laboratory (CSHL) and 20 other major research institutions in the U.S. and Europe have issued a major challenge to the neuroscience community.

1 Apr 2009

By shutting down inflammation, agent reverses damage from spinal cord injury in preclinical studies

Researchers at Georgetown University Medical Center (GUMC) have been able to speed recovery and substantially reduce damage resulting from spinal cord injury in preclinical studies.

1 Apr 2009

Model brain explains limitations of working memory

Researchers at the Swedish medical university Karolinska Institutet (KI) have constructed a mathematical activity model of the brain's anterior and superior parts, to increase the understanding of the capacity of the working memory and of how the billions of neurons in the brain interact.

31 Mar 2009

New brain mapping capabilities come to desktops of scientists worldwide

Mapping the billions of connections in the brain is a grand challenge in neuroscience.

30 Mar 2009

Eli Lilly announces inconclusive study results for mGlu2/3 in acute schizophrenia

Eli Lilly and Company has announced inconclusive Phase II clinical trial results from Study HBBI investigating LY2140023 monohydrate, also known as mGlu2/3, for the treatment of patients suffering from acute schizophrenia.

29 Mar 2009

Action video games improve real-world vision

Video games that involve high levels of action, such as first-person-shooter games, increase a player's real-world vision, according to research in today's Nature Neuroscience.

29 Mar 2009

Discovery of mechanism of neurodegeneration in Alzheimer's disease

Tiny, toxic protein particles severely disrupt neurotransmission and inhibit delivery of key proteins in Alzheimer's disease, two separate studies by Marine Biological Laboratory (MBL) researchers have found.

29 Mar 2009

Salk Institute forms strategic alliance agreement with sanofi-aventis

The Salk Institute has announced that it has signed a strategic alliance agreement with sanofi-aventis, establishing a joint program that supports cutting-edge research and promotes an exchange of discoveries focused on scientific advances and therapeutic applications.

29 Mar 2009

Experimental Parkinson's therapy may have robust weight-loss effect

A growth factor used in clinical experiments to rescue dying brain cells in Parkinson patients may cause unwanted weight loss if delivered to specific areas of the brain, according to University of Florida researchers in the March online edition of Molecular Therapy.

24 Mar 2009

Activity in one brain structure can predict people's preferences

The study shows that even when people rate options similarly, they will choose the one that causes more activation in the caudate nucleus, a brain region involved in anticipating reward.

24 Mar 2009

Social isolation makes strokes more deadly in mice

New research in mice suggests that social isolation may promote more damaging inflammation in the brain during a stroke.

23 Mar 2009

p11 protein may lead to faster acting antidepressants

Research conducted by Nobel laureate Paul Greengard, Medical Director of The Michael Stern Parkinson's Research Center at The Rockefeller University, Dr. Jennifer L. Warner-Schmidt in New York and colleagues in Sweden, demonstrated in the Journal of Neuroscience that the brain protein called p11 could lead pharmaceutical companies to develop anti-depression drugs that begin working within hours or days rather than the weeks or even months required by current drugs.

23 Mar 2009

FDA approves Symbyax for treatment-resistant depression

The U.S. Food and Drug Administration (FDA) has approved a new indication for Symbyax (olanzapine and fluoxetine HCl capsules), Eli Lilly and Company has announced.

23 Mar 2009

Astrocytes help separate man from mouse

A type of brain cell that was long overlooked by researchers embodies one of very few ways in which the human brain differs fundamentally from that of a mouse or rat, according to researchers who published their findings as the cover story in the March 11 issue of the Journal of Neuroscience.

23 Mar 2009

Insights into Parkinson's disease and deep-brain stimulation

About the only thing doctors have understood about deep-brain stimulation, which is widely used to treat Parkinson's disease symptoms, is that somehow it works for many patients.

20 Mar 2009

Novel stimulation method sparks hope for Parkinson's disease sufferers

A novel stimulation method, the first potential therapy to target the spinal cord instead of the brain, may offer an effective and less invasive approach for Parkinson's disease treatment, according to pre-clinical data published in the journal Science by researchers at Duke University Medical Center.

20 Mar 2009